Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Carhart-Harris RL, Friston KJ

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (0)

No references identified in the available metadata. This does not establish that none exist.

    Cited by — these papers cite this paper (54)

    1. Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model 2026-12-01 · Expand citations
    2. From Altered States to Fundamental Peace: Taxonomies of Consciousness, Psychedelics and Hypnosis Through the Lens of the Yoga Vāsiṣṭha 2026-10-18 · Expand citations
    3. Mystical experiences mediate the effects of psilocybin-assisted psychotherapy + mindfulness-based stress reduction on trait mindfulness and depression symptoms: mechanistic results from a randomized controlled trial 2026-10-11 · Expand citations
    4. Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD 2026-09-08 · Expand citations
    5. Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders 2026-09-02 · Expand citations
    6. HORMONAL MODULATION OF PSILOCYBIN RESPONSIVITY ACROSS THE FEMALE REPRODUCTIVE LIFESPAN 2026-08-31 · Expand citations
    7. Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy 2026-08-13 · Expand citations
    8. Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework 2026-08-12 · Expand citations
    9. Retreat from racism: A psychedelic group experience for racial stress and trauma 2026-07-30 · Expand citations
    10. Longitudinal neural and psychological changes following psilocybin under compassion imagery priming 2026-07-22 · Expand citations
    11. Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits 2026-07-01 · Expand citations
    12. Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults” 2026-06-30 · Expand citations
    13. Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations 2026-06-01 · Expand citations
    14. Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care 2026-05-14 · Expand citations
    15. A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder 2026-05-01 · Expand citations
    16. Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybin 2026-04-10 · Expand citations
    17. Classic psychedelics in obsessive-compulsive disorder: a circuit-based framework 2026-03-31 · Expand citations
    18. Classic psychedelic medicines for adolescent refractory mental health disease 2026-03-26 · Expand citations
    19. Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors 2026-03-26 · Expand citations
    20. “You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice 2026-03-22 · Expand citations
    21. Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies 2026-03-19 · Expand citations
    22. Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review 2026-03-09 · Expand citations
    23. Pilot study of psilocybin in patients with post-treatment lyme disease 2026-02-25 · Expand citations
    24. Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot Study 2026-02-03 · Expand citations
    25. THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS 2026-01-22 · Expand citations
    26. A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience 2025-11-30 · Expand citations
    27. Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects 2025-11-30 · Expand citations
    28. Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review 2025-11-24 · Expand citations
    29. Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports 2025-11-20 · Expand citations
    30. A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens 2025-11-14 · Expand citations
    31. The THRIVE Model of Psychedelic Integration: A Holistic Framework Bridging Indigenous Knowledge and Evidence-Based Practice 2025-10-19 · Expand citations
    32. Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review 2025-09-29 · Expand citations
    33. PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH 2025-09-01 · Expand citations
    34. Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report 2025-09-01 · Expand citations
    35. Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung 2025-05-01 · Expand citations
    36. The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”? 2025-03-14 · Expand citations
    37. Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression 2024-08-05 · Expand citations
    38. Psychedelic Mysticism and Christian Spirituality: From Science to Love 2024-04-26 · Expand citations
    39. Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review 2024-04-18 · Expand citations
    40. Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder 2024-03-07 · Expand citations
    41. Psychedelics: The New Kid on the Block 2024-01-01 · Expand citations
    42. Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings 2023-07-17 · Expand citations
    43. The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy 2023-02-11 · Expand citations
    44. Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer) 2022-10-03 · Expand citations
    45. SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies? 2022-01-01 · Expand citations
    46. Psychedelic Epistemology: William James and the “Noetic Quality” of Mystical Experience 2021-11-29 · Expand citations
    47. Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case study 2021-09-28 · Expand citations
    48. New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy 2021-09-10 · Expand citations
    49. Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience 2021-09-01 · Expand citations
    50. Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa 2021-06-24 · Expand citations
    51. Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis 2021-06-12 · Expand citations
    52. Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands 2021-04-16 · Expand citations
    53. A potential role for psilocybin in the treatment of obsessive-compulsive disorder 2020-06-01 · Expand citations
    54. The Varieties of Psychedelic Epistemology 2019-10-31 · Expand citations